Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
<h4>Importance</h4>Clinical guidelines currently recommend against amyloid imaging for cognitively unimpaired persons. The goal of Alzheimer's disease (AD) prevention, together with advances in understanding the pathophysiology of AD, however, has led to trials testing drugs in cogn...
Main Authors: | Emily A Largent, Kristin Harkins, Christopher H van Dyck, Sara Hachey, Pamela Sankar, Jason Karlawish |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229137 |
Similar Items
-
Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
by: Joshua D. Grill, et al.
Published: (2018-12-01) -
Response to “Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure”
by: Joshua D. Grill, et al.
Published: (2019-06-01) -
The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults
by: Philip S. Insel, et al.
Published: (2020-05-01) -
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
by: Mary M. Ryan, et al.
Published: (2021-08-01) -
Quantitative informant‐ and self‐reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4
by: Gonzalo Sánchez‐Benavides, et al.
Published: (2020-01-01)